Clinical Trials Directory

Trials / Sponsors / PharmaEssentia

PharmaEssentia

Industry · 17 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingEfficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera
Polycythemia Vera, Myeloproliferative Neoplasm
Phase 42026-02-01
RecruitingP1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk
Primary Myelofibrosis, Myeloproliferative Neoplasm
Phase 32025-07-18
Enrolling By InvitationPhase I Open-Label Study of P1101 Followed by P1801 in Advanced Solid Tumors
Advanced Solid Tumors
Phase 12025-04-21
CompletedA Phase I PK/PD Study of PEG-MetHuG-CSF (P2203) in Healthy Volunteers
PK in Healthy Volunteers
Phase 12024-08-19
RecruitingHLA-A*02:01 Allele Frequency and the NY-ESO-1 Expression Status in Cancer Patients in Taiwan
Solid Tumor Malignancy
—2023-03-14
Active Not RecruitingA Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV
Polycythemia Vera
Phase 32022-10-26
Active Not RecruitingA Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET
Essential Thrombocythemia
Phase 22022-09-29
CompletedThe Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-
Chronic Hepatitis B Infection, Chronic Hepatitis D Infection
Phase 12022-08-17
CompletedA Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or S
Actinic Keratosis
Phase 32021-12-21
CompletedSafety Evaluation of KX01 Ointment 1% in Japanese Healthy Male Subjects
Healthy Volunteer
Phase 12021-11-16
Active Not RecruitingA Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU
Polycythemia Vera
Phase 22021-10-08
CompletedThe Pharmacokinetics of P1101 + Ribavirin in Interferon Treatment-Naïve Subjects With Chronic Hepatitis C Viru
Hepatitis C, Chronic
Phase 12020-11-26
Active Not RecruitingRopeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistan
Essential Thrombocythemia
Phase 32020-08-25
CompletedRopeginterferon Alfa-2b (P1101) Phase 3 Study in Interferon Treatment-Naive Subjects With HCV Genotype 2 Infec
Chronic Hepatitis C Virus Infection
Phase 32016-01-12
CompletedKX01 Ointment Phase 1 Study in Patients With Plaque Type Psoriasis
Psoriasis
Phase 12015-10-27
CompletedDose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Viru
Hepatitis C, Chronic
Phase 22011-10-18
CompletedSingle Dose Escalation Study of P1101 in Healthy Adult Male Subjects
Healthy Volunteers
Phase 12009-11-07